First noticed in nursing hospitals in the early 1960′s, MRSA has had a relatively short existence. Until the mid-20th century, infectious diseases were the leading cause of death. Thanks to our good friend Alexander Fleming’s accidental discovery of penicillin in 1928, history shows a huge decrease in the incidences of diseases caused by bacteria throughout the early 20th century. Fleming’s discovery took a little while to gain traction, but when it did in the early 1940′s, it kick-started the era of the “Antibiotic Phenomenon”. Hailed as miracle drugs, these simple pills provided remarkable cures for previously untreatable conditions. Unfortunately, antibiotics do not provide a happily-ever-after story.
Just a decade later, a resistant strain of Staphylococcus Aureus emerged. It not only showed resistance to penicillin, but also to newer antibiotics in development such as: erythromycin, streptomycin, and tetracycline. The emergence of this super bacteria afforded a very costly lesson: Bacteria have the ability to mutate. Learn more about this superbug as seasoned, Registered Nurse, Donn Kropp, demystifies this scourge.
Upon completion of this course you will be able to:
- Understand bacteria and their significance
- Differentiate between Staphylococcus Aureus and MRSA
- Understand the origins of MRSA and its ramifications on health
- Gain knowledge about colonization vs infection
- Be enlightened about the mechanisms of bacterial mutation and resistance
- Learn how to identify, manage and prevent MRSA infections
- Understand treatment options
- Know the importance of instituting safe and effective infection control practices
- Understanding Bacteria
- Staph. vs MRSA
- Origins of MRSA
- Colonization vs Infection
- Mutation and Resistance
- Identify, Manage, Prevent
- Treatment Options
Course Approvals: This course is approved by the following governing boards & organizations:
- NAB: This educational offering has been reviewed by the National Continuing Education Review Service (NCERS) of the National Association of Boards of Examiners of Long Term Care Administrators (NAB).
- California Adult Residential Facility (ARF) Vendor No. 2000149-735-2 Course Approval No. ____________
- Residential Care Facility for the Elderly (RCFE) Vendor No. 2000149-740-2 Course Approval No._________
- Group Home (GH) Vendor No. 2000149-730-2 Course Approval No. __________
- CA Board of Registered Nursing: CA Provider # CEP 15849
- District of Columbia Board of Nursing: CE Provider #50-14108
- California Board of Vocational Nursing Provider # V10718
- Psychiatric Technicians Provider # V10722
- CA Department of Public Health, Aide & Technician Certification Section: Nurse Aide Certification #7028
- DSS/CCL Division for Adult Residential Facilities (ARF) Vendor Approval # 2000149-735-2: Course Approval # 149-0312-24234
- DSS/CCL Division for Residential Facilities for the Elderly (RCFE) Vendor Approval # 2000149-740-2: Course Approval # 149-0312-24238
- DSS/CCL Division for Group Homes (GH) Vendor Approval # 2000149-730-2: Course Approval # 149-0312-24230
- Far Northern Regional Center
- CA Department of Health Services, Aid & Technician Certification Section: Nurse Aide Certificate No._____________.
Writer(s): Donn Kropp, RN, BSN
- Jevons MP, Coe AW, Parker MT. Methicillin resistance in staphylococci. Lancet. Apr 27 1963;1:904-7.
- Elston DM. Handling a community-acquired methicillin-resistant Staphylococcus aureus outbreak: emerging data. Cutis. Aug 2008;82(2 Suppl 2):13-7
- Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. Mar 2005;45(3):311-20.
- Wulf MW, Sorum M, van Nes A, et al. Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin Microbiol Infect. Jan 2008;14(1):29-34
- Tacconelli E. Methicillin-resistant Staphylococcus aureus: risk assessment and infection control policies. Clin Microbiol Infect. Jan 11 2008;epub ahead of print.
- Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-e55.
Disclaimer: Cosine Health Strategies, LLC presents information which is based upon best efforts to reflect accepted medical and health-related practices at the time of posting. The medical and healthcare field is a dynamic profession with new information and better practices continuously being developed. Cosine Health Strategies, LLC assumes no liability or responsibility for errors or omissions in information. Cosine Health Strategies, LLC disclaims all responsibility for the use and application of information and for adverse effects resulting directly or indirectly from the use of information, from undetected errors, or from the user’s misunderstanding of the information. Cosine Health Strategies, LLC assumes no responsibility for the use of information; therefore, Cosine Health Strategies, LLC assumes no liability for any loss, damage, or expense from errors or omissions in the information, whether arising in contract, tort, or otherwise. Our lawyers make us say this.
Disclosures: Donn Kropp has disclosed no relevant financial relationships. Our lawyers make us say this, too.